Civil money penalties
This article was originally published in The Gray Sheet
Executive Summary
FDA is extending to Aug. 25 the comment period on its proposed rule "to establish hearing procedures when a hearing is requested concerning" the imposition of civil money penalties for medical devices, drugs and biologics, according to a July 27 Federal Register announcement.